Company / Gross Margin
CHINA PHARMA HOLDINGS, INC. Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
-3.2%
FY2025
5-year range
-6.1% / 18.0%
FY2021-FY2025
Trend
+20.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has fluctuated over the past 10 years, ranging from -6.1% in FY2022 to 20.7% in FY2017.
Based on SEC 10-K filings.
-3.2% in FY2025 with a 5-year CAGR of -16.8%.
Improved from -4.0% to -3.2% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +2.9pp
- 5-Year Change
- -16.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin increased 20.7% year-over-year.
- Peak gross margin was recorded in FY2017.
- Lowest gross margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3.2% | +20.7% |
| FY2024 | -4.0% | +0.0% |
| FY2023 | -4.0% | +34.2% |
| FY2022 | -6.1% | -133.9% |
| FY2021 | 18.0% | +32.4% |
| FY2020 | 13.6% | -15.3% |
| FY2019 | 16.0% | -14.2% |
| FY2018 | 18.7% | -9.6% |
| FY2017 | 20.7% | +187.1% |
| FY2016 | 7.2% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026